Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene in Women With AD
NCT00368459Phase 2Completed
- Sponsor
- Stanford University
- Start
- Aug 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raloxifene in Alzheimer's disease (AD), sponsored by Stanford University. Started Aug 2006; status: completed.
02
Drugs
raloxifene
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00368459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368459.